FDARecall 99893Medicines
What to do
The FDA record of this recall has no instruction for consumers. Compare the lot codes below with your product. If they match, do not use it, and follow the notice of the firm or ask the store where you bought it. Talk to your pharmacist or doctor before stopping a medicine.Note from Recalls Watch, not agency text.
Read the official notice on accessdata.fda.gov (opens in a new tab)
Hazard
Why it was recalled
Failed Dissolution Specifications: below specification
FDA classification: Class II. Use may cause temporary or medically reversible health consequences, or the chance of serious consequences is remote. Status: Ongoing.
Is it yours? Products and codes
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
- Lot or code
- Lot: DJ25134, Exp 11/30/2028
- FDA recall number
- D-0010-2027
Distribution (FDA): Nationwide in the US.
About this record
- Issued by
- U.S. Food and Drug Administration
- Firm
- Ajanta Pharma USA Inc (other notices of this firm)
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.